Wild type and tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity

Journal of Alzheimer's Disease

Volumn 27, Issue 2, 2011, Pages 441-452

  Kim, Woojin S ^a,b   Hill, Andrew F ^c,d   Fitzgerald, Michael L ^e   Freeman, Mason W ^e   Evin, Genevieve ^d,f   Garner, Brett ^a,g  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

ABCA1; Alzheimer's disease; A PP processing; lipid transport; membrane biology; Tangier disease

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; AMYLOID BETA PROTEIN; MEMBRANE LIPID;

ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; IMMUNOPRECIPITATION; LIPID TRANSPORT; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANGIER DISEASE; WILD TYPE;

EID: 81855190656     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110521     Document Type: Article

References (62)

1. Schmitz G, Kaminski WE, Orso E (2000) ABC transporters in cellular lipid trafficking. Curr Opin Lipidol 11, 493-501.
2. Kaminski WE, Piehler A, Wenzel JJ (2006) ABC A-subfamily transporters:Structure, function anddisease. Biochim Biophys Acta 1762, 510-524.
3. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22, 347-351. (Pubitemid 29369524)
4. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Gen-est J. Jr, Hayden MR (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22, 336-345. (Pubitemid 29369523)
5. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104, R25-R31. (Pubitemid 29536327)
6. Kim WS, Weickert CS, Garner B (2008) Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem 104, 1145-1166. (Pubitemid 351293350)
7. Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA, DeKosky ST, Lazo JS (2003) 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J Biol Chem 278, 13244-13256. (Pubitemid 36800094)
8. Karten B, Campenot RB, Vance DE, Vance JE (2006) Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J Biol Chem 281, 4049-4057. (Pubitemid 43847830)
9. Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, deVente J, Groen AK, Wellington CL, Kuipers F, Mulder M (2006) 24 (S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astro-cytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem 281, 12799-12808. (Pubitemid 43855372)
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82, 239-259.
11. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
12. Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881. (Pubitemid 27377060)
13. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
14. Sun Y, Yao J, Kim TW, Tall AR (2003) Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J Biol Chem 278, 27688-27694. (Pubitemid 36899957)
15. Kim WS, Suryo Rahmanto A, Kamili A, Rye KA, Guillemin GJ, Gelissen IC, Jessup W, Hill AF, Garner B (2007) Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein-E discs and suppression of amyloid-beta peptide generation. J Biol Chem 282, 2851-2861. (Pubitemid 47084333)
16. Vetrivel KS, Thinakaran G (2010) Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim Bio-phys Acta 1801, 860-867.
17. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95, 6460-6464. (Pubitemid 28249035)
18. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R, Hartmann T (2002) Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22, 1679-1689. (Pubitemid 35386286)
19. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. (Pubitemid 17054046)
20. Landry YD, Denis M, Nandi S, Bell S, Vaughan AM, Zha X (2006) ABCA1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem 281, 36091-36101. (Pubitemid 46041342)
21. Vaughan AM, Oram JF (2003) ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res 44, 1373-1380. (Pubitemid 37279619)
22. Zarubica A, Plazzo AP, Stockl M, Trombik T, Hamon Y, Muller P, Pomorski T, Herrmann A, Chimini G (2009) Functional implications of the influence of ABCA1 on lipid microenvironment at the plasma membrane: A biophysical study. FASEB J 23, 1775-1785.
23. Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, Thomas MJ, Hiltbold EM, Fessler MB, Parks JS (2010) Macrophage ABCA1 reduces MyD88 dependent toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res 51, 3196-3206.
24. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW (2002) Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 277, 33178-33187. (Pubitemid 34984836)
25. Fitzgerald ML, Okuhira K, Short GF, 3rd, Manning JJ, Bell SA, Freeman MW (2004) ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J Biol Chem 279, 48477-48485. (Pubitemid 39541006)
26. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, Masters CL (2006) Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281, 17670-17680. (Pubitemid 44035565)
27. Glaros EN, Kim WS, Quinn CM, Wong J, Gelissen I, Jes-sup W, Garner B (2005) Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apoA-I pathway. 1-Phenyl-2-Decanoylamino-3-Morpholino-1-Propanol is a novel cholesterol efflux accelerator. J Biol Chem 280, 24515-24523. (Pubitemid 40934537)
28. Rye KA, Garrety KH, Barter PJ (1993) Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipopro-tein A-I and A-II. Biochim Biophys Acta 1167, 316-325. (Pubitemid 23124026)
29. Li H, Kim WS, Guilemin GJ, Hill AF, Evin G, Garner B (2010) Modulation of amyloid precursor protein processing by synthetic ceramide analogues. Biochim Biophys Acta1801, 887-895.
30. Sharples RA, Vella LJ, Nisbet RM, Naylor R, Perez K, Barnham KJ, Masters CL, Hill AF (2008) Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J 22, 1469-1478. (Pubitemid 351656787)
31. Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, Evin G (2011) Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Neurobiol Dis 43, 176-183.
32. Kim WS, Guillemin GJ, Glaros EN, Lim CK, Garner B (2006) Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport 17, 891-896. (Pubitemid 43869954)
33. Adam RM, Yang W, Di Vizio D, Mukhopadhyay NK, Steen H (2008) Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis. BMC Cell Bio 9, 30.
34. Umeda T, Mori H, Zheng H, Tomiyama T (2010) Regulation of cholesterol efflux by amyloid beta secretion. J Neurosci Res 88, 1985-1994.
35. Chan SL, Kim WS, Kwok JB, Hill AF, Cappai R, Rye KA, Garner B (2008) ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem 106, 793-804.
36. Tanaka AR, Abe-Dohmae S, Ohnishi T, Aoki R, Morinaga G, Okuhira K, Ikeda Y, Kano F, Matsuo M, Kioka N, Amachi T, Murata M, Yokoyama S, Ueda K (2003) Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis. J Biol Chem 278, 8815-8819. (Pubitemid 36800640)
37. Eggert S, Midthune B, Cottrell B, Koo EH (2009) Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production. J Biol Chem 284, 28943-28952.
38. Trommsdorff M, Borg JP, Margolis B, Herz J (1998) Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 273, 33556-33560. (Pubitemid 29005740)
39. Tomita S, Fujita T, Kirino Y, Suzuki T (2000) PDZ domain-dependent suppression of NF-kappaB/p65-induced Abeta42 productionbyaneuron-specific X11-like protein. J Biol Chem 275, 13056-13060. (Pubitemid 30241467)
40. Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH (2002) The cytoplasmic domain of the LDL receptor-related protein regulates multiple stepsinAPP processing. EMBO J21, 5691-5700. (Pubitemid 35315269)
41. Nunan J, Williamson NA, Hill AF, Sernee MF, Masters CL, Small DH (2003) Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein. J Neurosci Res 74, 378-385. (Pubitemid 37362814)
42. Andersen OM, Schmidt V, Spoelgen R, Gliemann J, Behlke J, Galatis D, McKinstry WJ, Parker MW, Masters CL, Hyman BT, Cappai R, Willnow TE (2006) Molecular dissection of the interaction between amyloid precursor protein and its neu-ronal trafficking receptor SorLA/LR11. Biochemistry (Mosc) 45, 2618-2628.
43. Suzuki T, Nakaya T (2008) Regulation of amyloid beta-protein precursorbyphosphorylation and protein interactions. J Biol Chem 283, 29633-29637.
44. Bu G, Cam J, Zerbinatti C (2006) LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci 1086, 35-53.
45. Bai Y, Markham K, Chen F, Weerasekera R, Watts J, Horne P, Wakutani Y, Bagshaw R, Mathews PM, Fraser PE, Westaway D, St George-Hyslop P, Schmitt-Ulms G (2008) The in vivo brain interactome of the amyloid precursor protein. Mol Cell Proteomics 7, 15-34. (Pubitemid 351255432)
46. Okuhira K, Fitzgerald ML, Sarracino DA, Manning JJ, Bell SA, Goss JL, Freeman MW (2005) Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. J Biol Chem 280, 39653-39664. (Pubitemid 41713925)
47. Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160, 113-123. (Pubitemid 36091721)
48. Vetrivel KS, Cheng H, Kim SH, Chen Y, Barnes NY, Parent AT, Sisodia SS, Thinakaran G (2005) Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J Biol Chem 280, 25892-25900. (Pubitemid 40962301)
49. Kalvodova L, Kahya N, Schwille P, Ehehalt R, Verkade P, Drechsel D, Simons K (2005) Lipids as modulators of proteolytic activity ofBACE: involvementof cholesterol, gly-cosphingolipids, and anionic phospholipids in vitro. J Biol Chem 280, 36815-36823. (Pubitemid 41587762)
50. Osenkowski P, Ye W, Wang R, Wolfe MS, Selkoe DJ (2008) Direct and potent regulation of gamma-secretase by its lipid microenvironment. J Biol Chem 283, 22529-22540.
51. Cossec JC, Marquer C, Panchal M, Lazar AN, Duyckaerts C, Potier MC (2010) Cholesterol changes in Alzheimer's dis-ease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta 1801, 839-845.
52. Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC (2010) Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801, 846-852.
53. Chen ZJ, Vulevic B, Ile KE, Soulika A, Davis W Jr, Reiner PB, Connop BP, Nathwani P, Trojanowski JQ, Tew KD (2004) Association of ABCA2 expression with determinants of Alzheimer's disease. FASEB J 18, 1129-1131. (Pubitemid 39561546)
54. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, Strickland DK (2000) Modulation of beta-amyloid precursor protein processing by the low density lipoproteinreceptor-related protein (LRP). Evidencethat LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 275, 7410-7415. (Pubitemid 30146296)
55. Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B (2006) The X11 proteins, Abeta production and Alzheimer's disease. Trends Neurosci 29, 280-285.
56. Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, Wouters F, Hell SW, Simons M (2008) Flotillin-dependent clustering of the amyloid precursor protein regulates its endo-cytosis and amyloidogenic processing in neurons. J Neurosci 28, 2874-2882. (Pubitemid 351398889)
57. Saito Y, Sano Y, Vassar R, Gandy S, Nakaya T, Yamamoto T, Suzuki T (2008) X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by beta-site-cleaving enzyme in brain. J Biol Chem 283, 35763-35771.
58. Li T, Ma G, Cai H, Price DL, Wong PC (2003) Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals. J Neurosci 23, 3272-3277. (Pubitemid 36531968)
59. Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted ApoE. J Biol Chem 279, 40987-40993. (Pubitemid 39287699)
60. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693. (Pubitemid 351778466)
61. Vance JE, Hayashi H (2010) Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta 1801, 806-818.
62. Kim WS, Bhatia S, Elliott DA, Agholme L, Kagedal K, McCann H, Halliday GM, Barnham KJ, Garner B (2010) Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons. J Alzheimers Dis 21, 193-205.